AXIM Biotechnologies, Inc. (AXIM)
OTCMKTS: AXIM · Delayed Price · USD
0.0090
+0.0023 (34.33%)
Jun 14, 2024, 9:59 AM EDT - Market open

AXIM Biotechnologies Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Year 20232022202120202019 2018 - 2011
Net Income
-8.06-5.96-16.52-6.73-6.77
Upgrade
Depreciation & Amortization
0.430.432.120.020.01
Upgrade
Share-Based Compensation
0.21.111.142.311.84
Upgrade
Other Operating Activities
6.42.3810.771.19-0.09
Upgrade
Operating Cash Flow
-1.03-2.04-2.49-3.22-5.02
Upgrade
Capital Expenditures
0-0.01-0.05-0.10
Upgrade
Acquisitions
0000.08-0.03
Upgrade
Change in Investments
-----0.38
Upgrade
Other Investing Activities
---0.030.75
Upgrade
Investing Cash Flow
0-0.01-0.050.010.35
Upgrade
Common Stock Issued
0.491.741.643.313.46
Upgrade
Share Repurchases
0.15025,00000
Upgrade
Other Financing Activities
0.8-0.0925,001-0.16-0.09
Upgrade
Financing Cash Flow
1.141.652.533.153.38
Upgrade
Net Cash Flow
0.11-0.41-0-0.05-1.29
Upgrade
Free Cash Flow
-1.03-2.05-2.54-3.31-5.02
Upgrade
Free Cash Flow Margin
-2607.67%-23132.80%-4196.59%--627.92%
Upgrade
Free Cash Flow Per Share
-0.00-0.01-0.02-0.03-0.08
Upgrade
Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.